Create value. Reduce risk. This is not only the way we run the company, but also how we support our customers. In an industry flooded with decades-old technologies that are largely ineffective and/or unproven in real world installations, AIRPHX provides continuous complete indoor disinfection technology that has been uniquely validated with field testing and clinical results in large, occupied spaces.When I was introduced to the AIRPHX technology, I immediately recognized the market opportunity for this cost-effective solution to indoor disinfection. Working closely with its inventor, we transformed this technology into a commercially viable product—focusing on verticals where healthy indoor environments are critical, such as hospitals and senior living facilities.Our products now accommodate a growing list of industries who prioritize safeguarding employees and customers from virus transmission risk—while also reducing disinfection costs.AIRPHX technology generates oxidizing molecules from ambient air, effectively eliminating pathogens like coronavirus, norovirus, influenza, rhinovirus, staph, and MRSA at a cellular level. Our patented solution not only eradicates these pathogens, but also eliminates associated odors. AIRPHX products are currently used to combat the spread of respiratory viruses in areas such as: Healthcare Facilities:• Health systems• Senior care facilities• Surgery centers• Doctor/dentist offices• Veterinary hospitalsRetail, Hospitality & Banking Industries:• Retail stores• Hotels• Restaurants• BanksFitness & Athletic Facilities:• Gyms• Colleges• High school athletic departmentsPlus, Food Processing Plants & Commercial Office BuildingsBy significantly reducing air and surface pathogens, AIRPHX units play a vital role in providing a safe environment for tenants, customers, clients, and staff in real-world occupied spaces. Our technology substantially mitigates risks associated with microorganisms and other pathogens.

Baker Botts is an international law firm recognized around the globe as a leading firm in the energy, technology, and life sciences sectors. I provide comprehensive legal advice to public and private companies, including private equity sponsors and their portfolio companies. Specializing in mergers and acquisitions, private equity transactions, and joint ventures, my focus is on corporate governance, securities law compliance, and general corporate matters. Throughout my career, I have gained substantial expertise in various industries, particularly energy, defense, and telecommunications. I served as lead counsel for one of the largest private equity sponsors in a variety of energy transactions.

O’Melveny & Myers is a global law firm with 18 offices and home to a talented team of more than 750 lawyers who help clients grow, protect their assets, and navigate the challenges of complex law and regulation.O’Melveny clients span diverse industries—from technology to healthcare/life sciences to real estate/REITs to retail/consumer services—and range from decades-old Fortune 500 public companies to newly-public emerging growth companies and smaller reporting companies. I headed the Washington office corporate department and served on the firmwide Policy Committee and the Executive Committee of the Policy Committee, as I cultivated deep experience in advising public companies on a variety of securities law compliance, disclosure, and corporate governance matters.

Headquartered in New York, the Firm specializes in litigation and corporate practices—particularly mergers and acquisitions and private equity—providing coordinated legal advice and transactional capability to clients around the globe.